A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis

Autor: Borucki, Michael J., Spritzler, John, Asmuth, David M. *, Gnann, John, Hirsch, Martin S., Nokta, Mostafa, Aweeka, Francesca, Nadler, Paul I., Sattler, Fred, Alston, Beverly, Nevin, Thomas T., Owens, Susan, Waterman, Karen, Hubbard, Larry, Caliendo, Angela, Pollard, Richard B.
Zdroj: In Antiviral Research 2004 64(2):103-111
Databáze: ScienceDirect